Sood AK - Search Results

1

Phase 1b-2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum-resistant or platinum-refractory epithelial ovarian cancer.

Fu S, Hu W, Iyer R, Kavanagh JJ, Coleman RL, Levenback CF, Sood AK, Wolf JK, Gershenson DM, Markman M, Hennessy BT, Kurzrock R, Bast RC Jr. Fu S, et al. Among authors: sood ak. Cancer. 2011 Apr 15;117(8):1661-9. doi: 10.1002/cncr.25701. Epub 2010 Nov 8. Cancer. 2011. PMID: 21472713 Free PMC article. Clinical Trial.

2

Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: a gynecologic oncology group study.

Bloss JD, Blessing JA, Behrens BC, Mannel RS, Rader JS, Sood AK, Markman M, Benda J. Bloss JD, et al. Among authors: sood ak. J Clin Oncol. 2002 Apr 1;20(7):1832-7. doi: 10.1200/JCO.2002.07.045. J Clin Oncol. 2002. PMID: 11919241 Clinical Trial.

3

The clinical significance of tumor cell-lined vasculature in ovarian carcinoma: implications for anti-vasculogenic therapy.

Sood AK, Fletcher MS, Zahn CM, Gruman LM, Coffin JE, Seftor EA, Hendrix MJ. Sood AK, et al. Cancer Biol Ther. 2002 Nov-Dec;1(6):661-4. doi: 10.4161/cbt.316. Cancer Biol Ther. 2002. PMID: 12642690 Free article.

4

Functional role of matrix metalloproteinases in ovarian tumor cell plasticity.

Sood AK, Fletcher MS, Coffin JE, Yang M, Seftor EA, Gruman LM, Gershenson DM, Hendrix MJ. Sood AK, et al. Am J Obstet Gynecol. 2004 Apr;190(4):899-909. doi: 10.1016/j.ajog.2004.02.011. Am J Obstet Gynecol. 2004. PMID: 15118611

5

Sequential intraperitoneal topotecan and oral etoposide chemotherapy in recurrent platinum-resistant ovarian carcinoma: results of a phase II trial.

Sood AK, Lush R, Geisler JP, Shahin MS, Sanders L, Sullivan D, Buller RE, Sorosky JI. Sood AK, et al. Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6080-5. doi: 10.1158/1078-0432.CCR-04-0574. Clin Cancer Res. 2004. PMID: 15447993 Clinical Trial.

6

Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion.

Sood AK, Coffin JE, Schneider GB, Fletcher MS, DeYoung BR, Gruman LM, Gershenson DM, Schaller MD, Hendrix MJ. Sood AK, et al. Am J Pathol. 2004 Oct;165(4):1087-95. doi: 10.1016/S0002-9440(10)63370-6. Am J Pathol. 2004. PMID: 15466376 Free PMC article.

7

Genomic instability is associated with lack of telomerase activation in ovarian cancer.

Landen CN, Klingelhutz A, Coffin JE, Sorosky JI, Sood AK. Landen CN, et al. Among authors: sood ak. Cancer Biol Ther. 2004 Dec;3(12):1250-3. doi: 10.4161/cbt.3.12.1235. Epub 2004 Dec 14. Cancer Biol Ther. 2004. PMID: 15477760 Free article.

8

Novel modification of the vertical rectus abdominis myocutaneous flap for neovagina creation.

Sood AK, Cooper BC, Sorosky JI, Ramirez PT, Levenback C. Sood AK, et al. Obstet Gynecol. 2005 Mar;105(3):514-8. doi: 10.1097/01.AOG.0000154158.41973.a2. Obstet Gynecol. 2005. PMID: 15738017

9

Fifth International Conference on Ovarian Cancer: challenges and opportunities.

Sood AK, Abu-Rustum NR, Barakat RR, Bodurka DC, Brown J, Donato ML, Poynor EA, Wolf JK, Gershenson DM. Sood AK, et al. Gynecol Oncol. 2005 Jun;97(3):916-23. doi: 10.1016/j.ygyno.2005.03.013. Gynecol Oncol. 2005. PMID: 15907981

10

Selected highlights from the 5th International Conference on Ovarian Cancer. Houston, TX, USA, 1-4 December 2004.

Sood AK, Coleman RL, Wolf JK, Gershenson DM. Sood AK, et al. Expert Opin Pharmacother. 2005 Jun;6(7):1269-75. doi: 10.1517/14656566.6.7.1269. Expert Opin Pharmacother. 2005. PMID: 15957979 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,158 results

Search Page

Filters